HMG-CoA还原酶抑制剂研究进展

被引：3

作者：

倪春峰

李志裕

机构：

[1] 中国药科大学药化教研室

来源：

海峡药学 | 2007年 / 08期

关键词：

他汀类; 降脂; 联合治疗;

D O I：

暂无

中图分类号：

R972.6 [];

学科分类号：

1007 ;

摘要：

他汀类药物因具有强大的降低LDL-C作用,是降血脂的一线药物,近来随着研究的深入和实际需要,联合用药越来越多。他汀类药物除具有降脂作用外,还有其他的心脑血管保护作用,如改善内皮功能、抗炎、抑制血栓形成等。同时,近年来研究发现,此类药物对于防治心血管病外的多种疾病有新的作用和用途。

引用

页码：12 / 15

页数：4

共 10 条

[1] 新型降脂药依泽替米贝的研究进展 [J].

梁磊 ;

廖端芳 .

国外医学药学分册., 2006, (02) :117-119

[2]

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis[J] . Mitsuhiro Yokoyama,Hideki Origasa,Masunori Matsuzaki,Yuji Matsuzawa,Yasushi Saito,Yuichi Ishikawa,Shinichi Oikawa,Jun Sasaki,Hitoshi Hishida,Hiroshige Itakura,Toru Kita,Akira Kitabatake,Noriaki Nakaya,Toshiie Sakata,Kazuyuki Shimada,Kunio Shirato.The Lancet . 2007 (9567)

[3] Comparison of effects, of Ezetimibe/Simvastatin versus Simvastatin versus Atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels [J].

Pearson, Thomas ;

Ballantyne, Christie ;

Sisk, Christine ;

Shah, Arvind ;

Veltri, Enrico ;

Maccubbin, Darbie .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12) :1706-1713

[4] Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER study) [J].

Ballantyne, Christie M. ;

Weiss, Robert ;

Moccetti, Tiziano ;

Vogt, Anja ;

Eber, Bernd ;

Sosef, Froukje ;

Duffield, Emma .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05) :673-680

[5] Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia [J].

Koh, KK ;

Quon, MJ ;

Han, SH ;

Chung, WJ ;

Ahn, JY ;

Seo, YH ;

Choi, IS ;

Shin, EK .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1649-1653

[6]

Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease[J] . Jean-Francois Dorval,Todd Anderson,Jean Buithieu,Sammy Chan,Stuart Hutchison,Thao Huynh,Jean Jobin,Eva Lonn,Paul Poirier,Lawrence Title,Ann Walling,Thang Tran,Ghyslain Boudreau,Francois Charbonneau,Jacques Genest.The American Journal of Cardiology . 2005 (2)

[7]

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A Double-Blind, Placebo-Controlled Study of Extended-Release Niacin on Atherosclerosis Progression in Secondary Prevention Patients Treated With Statins[J] . Allen J. Taylor,Lance E. Sullenberger,Hyun J. Lee,Jeannie K. Lee,Karen A. Grace.Circulation . 2004 (23)

[8] Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia [J].

Ballantyne, CM ;

Blazing, MA ;

King, TR ;

Brady, WE ;

Palmisano, J .

AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) :1487-1494

[9] Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined Hyperlipidemia and metabolic syndrome [J].

Vega, GL ;

Ma, PTS ;

Cater, NB ;

Filipchuk, N ;

Meguro, S ;

Garcia-Garcia, AB ;

Grundy, SM .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (08) :956-960

[10]

Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)[J] . Mitsuhiro Yokoyama,Hideki Origasa.American Heart Journal . 2003 (4)

← 1 →